LGVN

Conviction 80HealthcareScan · Tue, Sep 8, 2026

LGVN$6.74-1.03%

ResistanceSupportVol 14

Vol MA14 445.74K

Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

Longeveron Inc.PHARMACEUTICAL PREPARATIONSwww.longeveron.com ↗

Price6.74

Change-1.03%

Gap-1.91%

Rel volume0.13×

Avg volume532.11K

Avg $ vol571.1K

SMA 203.16

SMA 501.66

SMA 2000.9638

Price vs 50+305.07%

Price vs 200+599.28%

MA stackbullish

50/200 crossgolden · 7d

Supertrendup · 4.98

RSI (14)88

MACD hist0.46

MACD crossbull · 7d

Stoch %K / %D92 / 91

ADX (14)54

+DI / −DI57 / 4

RSI divergence—

MACD divergence—

ATR %+7.49%

ADR %8.80%

52w high6.90

52w low0.4836

From 52w high-2.32%

Above 52w low+1293.71%

New 52w highNo

SqueezeOff

Bollinger width371.30%

%B0.80

Donchian pos91.59%

Donchian high7.30

Donchian low0.6500

AVWAP (52w high)6.80

vs AVWAP high-0.89%

AVWAP (52w low)0.9028

vs AVWAP low+646.61%

OBV trendFlat

Chaikin MF (20)-0.16

Today vs 20d0.13×

Avg vol (14d)445.74K

Avg vol (20d)532.11K

Avg $ vol (20d)571.1K

Market cap118.47B

RS 3m (vs SPY)+828.45%

RS 6m (vs SPY)+1293.64%

RS line new highNo

Trend template8/8

Technical rank95.9

1 week-2.32%

1 month+779.90%

3 months+793.90%

6 months+1172.90%

1 year+751.23%

YTD+1036.59%

P/E-5217.85

P/B—

P/S—

P/FCF—

EPS-1.29

Div yield—

ROE-218.27%

ROA-146.60%

Debt/Eq0.01

Current2.63

EV/EBITDA—

Gross margin66.97%

Net margin—

Rev growth-49.87%

EPS growth-42.14%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value118.46B

Revenue287K

Net income-6.07M

Gross profit182K

Free cash flow-18.89M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out30.15M

Employees38

ListedFri, Feb 12, 2021

Free float19.66M

Float %90.3%

Short interest1.7M

Days to cover3.4d

Short volume66.9%

Squeeze score52 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank95.9 / 100

Group rank96 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.09

Support0.5806

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LGVN

All disclosures →

No recent disclosed trades by Congress in LGVN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LGVN · 10 buys

Insider	Side	Shares	Value	Traded	Filed
Jhaveri Nirav S. Chief Financial Officer · Class A Common Stock · 2026-08-17	Grant	300K	—	2026-08-17	2026-08-25
Blass Devin CTO & SVP of CMC · Class A Common Stock · 2026-08-19	Grant	286K	—	2026-08-19	2026-08-21
Agafonova Nataliya Chief Medical Officer · Class A Common Stock · 2026-08-19	Grant	286K	—	2026-08-19	2026-08-21
Ascheim Deborah Director · Class A Common Stock · 2026-08-19	Grant	36K	—	2026-08-19	2026-08-21
Cann Leah Rush Director · Class A Common Stock · 2026-08-19	Grant	36K	—	2026-08-19	2026-08-21
Desai Arjun JJ Director · Class A Common Stock · 2026-08-19	Grant	36K	—	2026-08-19	2026-08-21
Hajjar Roger Joseph Director · Class A Common Stock · 2026-08-19	Grant	36K	—	2026-08-19	2026-08-21
Hare Joshua Chief Scientific Officer · Class A Common Stock · 2026-08-19	Grant	286K	—	2026-08-19	2026-08-21
Lehr Paul T General Counsel, Secretary · Class A Common Stock · 2026-08-19	Grant	286K	—	2026-08-19	2026-08-21
Ungaro Ursula Director · Class A Common Stock · 2026-08-19	Grant	36K	—	2026-08-19	2026-08-21

SEC filings

EDGAR filings in LGVN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

LGVN

Recent news

Get daily signals & real-time alerts.